These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17718717)

  • 21. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
    Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
    Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor-1 (IGF-1)-derived peptide protects against diabetes in NOD mice.
    Kodama K; Shimada A; Funae O; Morimoto J; Irie J; Shigihara T; Oikawa Y; Tokui M; Watanabe K; Saruta T
    Autoimmunity; 2004; 37(6-7):481-7. PubMed ID: 15621575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA vaccination with glutamic acid decarboxylase (GAD) generates a strong humoral immune response in BALB/c, C57BL/6, and in diabetes-prone NOD mice.
    Wiest-Ladenburger U; Fortnagel A; Richter W; Reimann J; Boehm BO
    Horm Metab Res; 1998 Oct; 30(10):605-9. PubMed ID: 9851666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.
    Silveira PA; Johnson E; Chapman HD; Bui T; Tisch RM; Serreze DV
    Eur J Immunol; 2002 Dec; 32(12):3657-66. PubMed ID: 12516557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of diabetes-prone or non-diabetes-prone mice with GAD65 does not induce diabetes or islet cell pathology.
    Plesner A; Worsaae A; Dyrberg T; Gotfredsen C; Michelsen BK; Petersen JS
    J Autoimmun; 1998 Aug; 11(4):335-41. PubMed ID: 9776711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
    Li AF; Hough J; Henderson D; Escher A
    Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse.
    Ziegler B; Augstein P; Lühder F; Northemann W; Hamann J; Schlosser M; Klöting I; Michaelis D; Ziegler M
    Diabetes Res; 1994; 25(2):47-64. PubMed ID: 7544254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
    Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice.
    Mor A; Kloog Y; Keren G; George J
    Eur J Pharmacol; 2009 Aug; 616(1-3):301-5. PubMed ID: 19527709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse.
    Joussemet B; Vu AT; Sai P; Bach JM
    Ann N Y Acad Sci; 2005 Jun; 1051():613-25. PubMed ID: 16127002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif.
    Herman AE; Tisch RM; Patel SD; Parry SL; Olson J; Noble JA; Cope AP; Cox B; Congia M; McDevitt2 HO
    J Immunol; 1999 Dec; 163(11):6275-82. PubMed ID: 10570321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
    Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J
    Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL
    Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
    Reich EP; von Grafenstein H; Barlow A; Swenson KE; Williams K; Janeway CA
    J Immunol; 1994 Mar; 152(5):2279-88. PubMed ID: 8133041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
    Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
    Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1.
    Nakazawa T; Satoh J; Takahashi K; Sakata Y; Ikehata F; Takizawa Y; Bando SI; Housai T; Li Y; Chen C; Masuda T; Kure S; Kato I; Takasawa S; Taniguchi T; Okamoto H; Toyota T
    J Autoimmun; 2001 Sep; 17(2):119-25. PubMed ID: 11591120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes.
    Lo D; Reilly CR; Scott B; Liblau R; McDevitt HO; Burkly LC
    Eur J Immunol; 1993 Jul; 23(7):1693-8. PubMed ID: 7686860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.
    Mizuno M; Masumura M; Tomi C; Chiba A; Oki S; Yamamura T; Miyake S
    J Autoimmun; 2004 Dec; 23(4):293-300. PubMed ID: 15571923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administering glutamic acid decarboxylase to NOD mice prevents diabetes.
    Tisch R; Yang XD; Liblau RS; McDevitt HO
    J Autoimmun; 1994 Dec; 7(6):845-50. PubMed ID: 7888040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.